利索-全球专利检索

  1. 登录
  2. 注册
发明授权
US09512167B2 Optimized synthesis of pure, non-polymorphic, crystalline bile acids with defined particle size 有权
优化了具有规定粒径的纯非多晶型结晶胆汁酸的合成

Optimized synthesis of pure, non-polymorphic, crystalline bile acids with defined particle size
摘要：
The present invention relates to a pure polymorph of Nor-UDCA or Bis-nor-UDCA, or of a pharmaceutically acceptable salt thereof. The invention further provides a pharmaceutical composition comprising the polymorph of the invention, and a method for preparing the polymorph. The invention includes the pharmaceutical use of the polymorph or of the pharmaceutical composition of the invention.
摘要（中）：

本发明涉及Nor-UDCA或Bis-nor-UDCA或其药学上可接受的盐的纯多晶型物。 本发明还提供了包含本发明多晶型物的药物组合物和制备该多晶型物的方法。 本发明包括本发明的多晶型物或药物组合物的药物用途。

公开/授权文献
信息查询
Espacenet
0/0